Breaking News Instant updates and real-time market news.

ORCL

Oracle

$46.18

-2.095 (-4.34%)

, KSS

Kohl's

$74.78

-0.93 (-1.23%)

10:05
06/14/18
06/14
10:05
06/14/18
10:05

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL) downgraded to Neutral from Overweight at JPMorgan with analyst Mark Murphy saying the shares have risen from the $30s into the high $40s over the last two years, but the company's fundamental performance has remained inconsistent. 2. Kohl's (KSS) downgraded to Neutral from Buy at Citi with analyst Paul Lejuez citing valuation. 3. Toll Brothers (TOL) downgraded to Hold from Buy at Zelman. 4. PGT, Inc. (PGTI) downgraded to Hold on valuation at Gabelli with analyst Alvaro Lacayo citing valuation. 5. XPO Logistics (XPO) downgraded to Neutral from Buy at BofA/Merrill with analyst Ariel Rosa citing limited upside following the recent gain in shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ORCL

Oracle

$46.18

-2.095 (-4.34%)

KSS

Kohl's

$74.78

-0.93 (-1.23%)

TOL

Toll Brothers

$38.31

-0.66 (-1.69%)

PGTI

PGT, Inc.

$20.50

-0.525 (-2.50%)

XPO

XPO Logistics

$111.21

-2.15 (-1.90%)

  • 19

    Jun

ORCL Oracle
$46.18

-2.095 (-4.34%)

06/14/18
JPMS
06/14/18
DOWNGRADE
Target $53
JPMS
Neutral
Oracle downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Mark Murphy downgraded Oracle to Neutral and lowered his price target for the shares to $53 from $55.
06/14/18
JPMS
06/14/18
DOWNGRADE
Target $53
JPMS
Neutral
JPMorgan downgrades Oracle after CIO survey shows spending contraction
JPMorgan analyst Mark Murphy downgraded Oracle (ORCL) to Neutral from Overweight and lowered his price target for the shares to $53 from $55. The stock closed yesterday down 18c to $48.27. The shares have risen from the $30s into the high $40s over the last two years, but the company's fundamental performance has remained inconsistent, Murphy tells investors in a research note. Further, the analyst notes that in his firm's recent survey of 154 chief investment officers, Oracle received the largest number of indications for planned spending contraction this year, materially more than the second-worst company. The CIOs indicate contraction in Oracle spending this year, placing the company alongside IBM (IBM), Checkpoint (CHKP), and CA (CA), Murphy contends. He notes the results of his firm's CIO surveys over the years "have been highly predictive."
06/14/18
NOMU
06/14/18
NO CHANGE
Target $60
NOMU
Buy
Oracle price target lowered to $60 from $64 at Nomura Instinet
Nomura Instinet analyst Christopher Eberle lowered his price target for Oracle to $60 ahead of the company's Q4 results on June 19. The analyst trimmed his estimates to account for currency and expectations for more modest revenue acceleration in fiscal 2019. He remains optimistic, however, on Oracle's transition and model growth reacceleration as the year progresses. Eberle keeps a Buy rating on the shares, which JPMorgan this morning downgraded to Neutral.
05/01/18
BERN
05/01/18
NO CHANGE
BERN
Amazon Aurora more expensive than oracle for enterprise workloads, says Bernstein
Bernstein analyst Mark Moerdler notes that there has been a generally held belief that Amazon (AMZN) Aurora was positioned to take customers and share from Oracle (ORCL) but that is "simply not true." Excluding the significant feature/functionality limitations of Aurora for the enterprise workloads that are core to the Oracle database business, Amazon has priced Aurora for small departmental workloads used possibly 8 hours a day/5 days a week, he contends. As the database workload grows in size and the data is accessed more frequently Aurora becomes less and less competitive, the analyst adds. Moerdler believes this debunks one major threat. For Amazon, he does not see this as a problem since there is a very large opportunity for departmental databases.
KSS Kohl's
$74.78

-0.93 (-1.23%)

06/14/18
SBSH
06/14/18
DOWNGRADE
SBSH
Neutral
Kohl's downgraded to Neutral from Buy at Citi
Citi analyst Paul Lejuez downgraded Kohl's to Neutral citing valuation following the recent rally in the shares.
06/07/18
JEFF
06/07/18
NO CHANGE
Target $115
JEFF
Buy
Kohl's price target raised to $115 from $100 at Jefferies
Jefferies analyst Randal Konik raised his price target for Kohl's to $115 after spending time with management and his real estate deep dive. Management highlighted peer closures as a "tremendous opportunity," something the Street is underappreciating, Konik tells investors in a research note. He keeps a Buy rating on Kohl's.
06/14/18
SBSH
06/14/18
DOWNGRADE
Target $75
SBSH
Neutral
Citi downgrades Kohl's to Neutral after 27% post-earnings rally
Citi analyst Paul Lejuez downgraded Kohl's to Neutral from Buy while raising his price target for the shares to $75 from $71. The stock is up 27% since the company reported "underwhelming" top line results on May 22, Lejuez tells investors in a research note. The analyst sees a more balanced risk/reward as current levels. While Q2 trends to date have improved, the Q1 sales shortfall is a reminder that the traffic challenges are real, the analyst contends.
06/08/18
BARD
06/08/18
NO CHANGE
Target $85
BARD
Outperform
Kohl's price target raised to $85 from $73 at Baird
Baird analyst Mark Altschwager raised his price target on Kohl's to $85 from $73 following meetings with management. The analyst sees the company maximizing its market share as competitors exit the marketplace. The analyst noted Q4 comps remain a high hurdle, but management expressed confidence in it ability to "comp the comp" based on momentum. Altschwager reiterated his Outperform rating on Kohl's shares.
TOL Toll Brothers
$38.31

-0.66 (-1.69%)

06/14/18
ZELM
06/14/18
DOWNGRADE
ZELM
Hold
Toll Brothers downgraded to Hold from Buy at Zelman
05/23/18
LEHM
05/23/18
NO CHANGE
Target $39
LEHM
Underweight
Toll Brothers price target lowered to $39 from $43 at Barclays
Barclays analyst Matthew Bouley lowered his price target for Toll Brothers to $39 and keeps an Underweight rating on the shares. The analyst sees heightened risk to 2018 estimates following the company's Q2 gross margin miss. Further, he's skeptical around the likelihood of the "large sequential margin step-up "required between Q3 and Q4 in order to achieve full-year guidance.
05/23/18
MKMP
05/23/18
NO CHANGE
Target $53
MKMP
Buy
Toll Brothers price target lowered to $53 from $60 at MKM Partners
MKM Partners analyst Megan McGrath lowered her price target on Toll Brothers to $53 after its Q2 earnings miss, saying his revised outlook also accounts for expectations of "slower community count growth this year as well as lower gross margin expectations next year." The analyst adds that while the management has indicated that higher interest rates are not impacting demand, she is increasingly concerned with the impact of rising rates and costs. McGrath keeps her Buy rating however, noting that Toll Brothers can show some resiliency with improving margins in the second half of the year if interest rates can stabilize.
05/23/18
FBCO
05/23/18
NO CHANGE
Target $46
FBCO
Neutral
Toll Brothers price target lowered to $46 from $53 at Credit Suisse
Credit Suisse analyst Susan Maklari lowered her price target for Toll Brothers to $46 from $53 as gross margin pressures weigh on results. The analyst reiterates a Neutral rating on the shares.
PGTI PGT, Inc.
$20.50

-0.525 (-2.50%)

06/14/18
GABE
06/14/18
DOWNGRADE
GABE
Hold
PGT, Inc. downgraded to Hold on valuation at Gabelli
Gabelli analyst Alvaro Lacayo downgraded PGT, Inc to Hold from Buy with a $22 private market value citing valuation.
08/04/17
RAJA
08/04/17
DOWNGRADE
RAJA
Market Perform
PGT, Inc. downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Sam Darkatsh downgraded PGT, Inc to Market Perform following the "terrific" Q2 saying he expects sales growth to moderate from here and sees increased execution risk due to the relocation of the Miami based operations into a new facility.
11/03/17
DOTC
11/03/17
UPGRADE
Target $18
DOTC
Buy
PGT, Inc. upgraded to Buy from Neutral at Dougherty
Dougherty analyst Jeremy Hamblin upgraded PGT, Inc. to Buy from Neutral, noting that sales trends have normalized in Q4, its recent agreement to sell its door glass processing assets lowers operating risk and its improved operating efficiency should allow margins to expand in FY18. He set an $18 price target on PGT, Inc. shares.
XPO XPO Logistics
$111.21

-2.15 (-1.90%)

06/14/18
DBAB
06/14/18
NO CHANGE
DBAB
Buy
Deutsche elevates Knight-Swift to top-pick status, says 'simply too cheap'
After hosting an investor dinner with management Deutsche Bank analyst Amit Mehrotra elevated Knight-Swift (KNX) shares to top-pick status across his entire 35-stock coverage universe, joining XPO Logistics (XPO). Knight-Swift shares are "simply too cheap" based on its prospective earnings growth opportunity, and already discount peak truckload fundamentals in 2019, Mehrotra tells investors in a research note. He sees little downside risk at current share levels, with "free" optionality that the current cycle will be longer and stronger than expectations, which he thinks will be the case.
05/02/18
DBAB
05/02/18
NO CHANGE
Target $133
DBAB
Buy
Deutsche sees last mile competition having 'muted' impact on XPO
Deutsche Bank analyst Amit Mehrotra highlights a Reuters report saying UPS (UPS) and Werner Enterprises (WERN) are in in talks to partner on a new in-home delivery service for bulk goods. This development follows Ryder's (R) acquisition last month of MXD Group, Mehrotra tells investors in an intraday research note. The analyst sees implications for XPO, noting the company's last mile delivery of heavy goods is one of its fastest growing businesses. Despite the headline risks, fundamental implications for XPO are likely "muted," Mehrotra contends. He believes XPO has built a competitive advantage around its owned service center model and sees the heavy goods last mile market, estimated at $13B per annum and growing at 10%-15%, as allowing for more entrants without much impact to existing players. XPO in morning trading is down 2% to $93.89. Mehrotra has a Buy rating on the shares with a $133 price target.
05/03/18
DBAB
05/03/18
NO CHANGE
DBAB
Buy
XPO results in-line and 'largely uneventful,' says Deutsche Bank
Deutsche Bank analyst Amit Mehrotra views XPO Logistics' Q1 results as in-line and "largely uneventful," which he says is fine with him. Organic growth was a bit better than expected and new business wins were impressive, but free cash flow was worse than expected, Mehrotra tells investors in a post-earnings research note. He believes the net impact on the shares is neutral and keeps a Buy rating on XPO.
06/14/18
BOFA
06/14/18
DOWNGRADE
BOFA
Buy
XPO Logistics downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Ariel Rosa downgraded XPO Logistics to Neutral from Buy and raised its price target to $117 from $105 citing limited upside following the recent gain in shares.

TODAY'S FREE FLY STORIES

AMGN

Amgen

$184.86

-1.14 (-0.61%)

12:23
06/23/18
06/23
12:23
06/23/18
12:23
Hot Stocks
Amgen's Repatha 'significantly reduced' LDL-C, non-HDL-C in Type 2 diabetes »

Amgen announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

12:18
06/23/18
06/23
12:18
06/23/18
12:18
Hot Stocks
Eli Lilly's Trulicity shows promise in delivering efficacy in type 2 diabetes »

Two investigational doses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

IRWD

Ironwood

$19.35

0.74 (3.98%)

12:14
06/23/18
06/23
12:14
06/23/18
12:14
Hot Stocks
Ironwood announced Praliciguat phase IIa study data »

Ironwood Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

12:07
06/23/18
06/23
12:07
06/23/18
12:07
Hot Stocks
Array BioPharma announces updated results from Phase 3 BEACON CRC trial »

Array BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

DDAIF

Daimler AG

$0.00

(0.00%)

, BMWYY

BMW

$0.00

(0.00%)

11:42
06/23/18
06/23
11:42
06/23/18
11:42
Periodicals
EU to respond to any U.S. auto tariffs, Reuters reports »

The EU will respond to…

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

, GE

General Electric

$13.05

0.29 (2.27%)

11:27
06/23/18
06/23
11:27
06/23/18
11:27
Periodicals
Adding Walgreens to Dow may be wrong move, Barron's says »

The guardians of Dow…

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

GE

General Electric

$13.05

0.29 (2.27%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

, C

Citi

$67.20

-0.43 (-0.64%)

11:04
06/23/18
06/23
11:04
06/23/18
11:04
Periodicals
Banks to get green light to increase dividends, share repurchases, Barron's says »

Big banks are expected to…

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

C

Citi

$67.20

-0.43 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 26

    Jul

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

MD

Mednax

$44.99

-0.11 (-0.24%)

10:59
06/23/18
06/23
10:59
06/23/18
10:59
Periodicals
Mednax shares may be at risk amid hospital fights, Barron's says »

After peaking in 2015,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

10:25
06/23/18
06/23
10:25
06/23/18
10:25
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

TWTR

Twitter

$45.90

0.68 (1.50%)

, FOXA

21st Century Fox

$48.59

0.25 (0.52%)

10:21
06/23/18
06/23
10:21
06/23/18
10:21
Periodicals
Biggest winner of World Cup could be Twitter, Barron's says »

Twitter's (TWTR)…

TWTR

Twitter

$45.90

0.68 (1.50%)

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

AAPL

Apple

$184.85

-0.63 (-0.34%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:10
06/23/18
06/23
10:10
06/23/18
10:10
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$184.85

-0.63 (-0.34%)

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

STMP

Stamps.com

$252.60

0.65 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

A

Agilent

$62.79

-0.24 (-0.38%)

, ABT

Abbott

$61.93

0.19 (0.31%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
American Diabetes Association to hold a conference »

78th Scientific Sessions…

A

Agilent

$62.79

-0.24 (-0.38%)

ABT

Abbott

$61.93

0.19 (0.31%)

AKCA

Akcea Therapeutics

$26.24

0.4 (1.55%)

AMGN

Amgen

$184.86

-1.14 (-0.61%)

AZN

AstraZeneca

$35.06

-0.095 (-0.27%)

BAYRY

Bayer

$0.00

(0.00%)

CL

Colgate-Palmolive

$64.63

1.15 (1.81%)

DXCM

DexCom

$99.52

-0.2 (-0.20%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

IRWD

Ironwood

$19.35

0.74 (3.98%)

JNJ

Johnson & Johnson

$122.81

1.36 (1.12%)

MDT

Medtronic

$86.80

0.51 (0.59%)

MNKD

MannKind

$1.98

0.02 (1.02%)

WAKE

Wake Forest Bancshares Inc.

$0.00

(0.00%)

VLRX

Valeritas

$1.39

0.035 (2.58%)

TNDM

TNDM

SNY

Sanofi

$39.98

0.96 (2.46%)

SIEGY

Siemens

$0.00

(0.00%)

SENS

Senseonics

$4.76

-0.2 (-4.03%)

REGN

Regeneron

$331.82

2.81 (0.85%)

PODD

Insulet

$97.37

0.5697 (0.59%)

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

MRK

Merck

$61.46

0.295 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 28

    Jun

  • 02

    Jul

  • 06

    Jul

  • 12

    Jul

  • 17

    Jul

  • 18

    Jul

  • 11

    Aug

  • 27

    Aug

  • 30

    Aug

  • 10

    Sep

  • 06

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Jan

  • 22

    Mar

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$74.81

-0.11 (-0.15%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
IntercontinentalExchange management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

AMGN

Amgen

$184.86

-1.14 (-0.61%)

, ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO World Congress on…

AMGN

Amgen

$184.86

-1.14 (-0.61%)

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

BAYRY

Bayer

$0.00

(0.00%)

HALO

Halozyme

$18.07

-0.52 (-2.80%)

INCY

Incyte

$74.02

1.55 (2.14%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

MRK

Merck

$61.46

0.295 (0.48%)

SHPG

Shire

$161.73

-0.7 (-0.43%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$39.98

0.96 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 28

    Jun

  • 30

    Jun

  • 30

    Jun

  • 10

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 21

    Dec

  • 28

    Jan

  • 22

    Mar

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

, PCG

PG&E

$42.98

2.44 (6.02%)

18:17
06/22/18
06/22
18:17
06/22/18
18:17
Hot Stocks
Northwest Natural to sell Gill Ranch Storage to SENSA Holdings »

NW Natural (NWN)…

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

PCG

PG&E

$42.98

2.44 (6.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ORLY

O'Reilly Automotive

$285.90

-1.18 (-0.41%)

18:03
06/22/18
06/22
18:03
06/22/18
18:03
Hot Stocks
O'Reilly Automotive's O'Reilly sells 19,250 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$33.15

0.02 (0.06%)

17:46
06/22/18
06/22
17:46
06/22/18
17:46
Hot Stocks
South Jersey Industries announces approval of Elizabethtown Gas purchase »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAAS

AquaVenture

$15.36

0.12 (0.79%)

17:27
06/22/18
06/22
17:27
06/22/18
17:27
Hot Stocks
AquaVenture extends long-stop date for Ghana plant acquisition to September 30 »

AquaVenture announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Periodicals
Nissan chooses Thailand for hybrid's first export market, Nikkei reports »

Nissan has planned to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$0.81

-0.0068 (-0.83%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Hot Stocks
Trovagene CEO William Welch resigns, Dr. Thomas Adams named interim CEO »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$3.26

0.005 (0.15%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.49

-0.15 (-0.45%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Hot Stocks
Aecom to compete for $148.5M U.S. Army contract »

AECOM-Baker JV, Bryan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:17
06/22/18
06/22
17:17
06/22/18
17:17
Hot Stocks
Lockheed Martin awarded $175.3M U.S. Navy contract modification »

Lockheed Martin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:16
06/22/18
06/22
17:16
06/22/18
17:16
Hot Stocks
Lockheed Martin awarded $1.12B U.S. Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.